The breakthrough new serialisation technology, known as Rigour+ for Manufacturers, was just unveiled by market leader Afrihealth, a provider of health technology solutions.
The product aims to make a significant impact on the pharmaceutical manufacturing and distribution industries not only in Nigeria but also elsewhere.
Additionally, it was announced that Linda Obi would take over as CEO of the company effective immediately. For the purpose of driving this mandate, Linda brings more than 18 years of experience in technology and blockchain.
Afrihealth has developed a new serialisation technology called Rigour+ for Manufacturers. This technology is intended to combat the urgent issue of drug counterfeiting, which is estimated to cost the pharmaceutical industry around the world approximately $200 billion each year.
Manufacturers and importers in Nigeria face significant pain points as a result of a lack of credible track and trace capabilities, which results in production losses of up to 40 percent and significant revenue losses. These problems are a direct result of the lack of credible track and trace capabilities.
Read also: How Technology Improves Healthcare in Africa
The impact of Afrihealth through Rigour+
Rigour+ for Manufacturers is an initiative that seeks to enhance the safety and quality of pharmaceutical products by assisting manufacturers and importers in meeting regulatory requirements. This will be accomplished through the implementation of track-and-trace capabilities as well as proper serialisation.
The technology enables manufacturers to track products at every stage of the supply chain and to quickly and efficiently recall products in the event of a problem. This is made possible by geofencing solutions and location recall, which are both included in the technology.
According to Linda Obi, Afrihealth’s new chief executive officer, “We are proud to introduce Rigour+ for Manufacturers to the Nigerian market and beyond, a powerful serialisation technology that saves manufacturers and importers time and money, optimises their production, and enables them to deliver high-quality products to patients in need.”
The implementation of serialisation technology in the Nigerian pharmaceutical industry could potentially save more than one hundred million dollars annually, as well as contribute to a reduction in the number of instances in which fake drugs are sold.
Rigour+ for manufacturers is properly aligned with regulatory bodies such as GS1 Nigeria and NAFDAC, which ensures that it complies with the most stringent safety and quality standards possible.
“Afrihealth’s Rigour+ is a local, in-country solution with a global impact,” remarked Linda Obi. “We are committed to providing the best technology solutions to our customers and making a positive impact on public health in Nigeria and beyond,” she added.
The team at Afrihealth is made up of highly skilled and experienced professionals who come from a variety of backgrounds and have extensive knowledge in the fields of technology, medicine, and pharmaceuticals.
The organisation has a good culture of innovation, collaboration, and social responsibility, and its mission is to enhance access to health care and ensure patient safety through technology-enabled solutions. This mission is supported by a strong culture of innovation, collaboration, and social responsibility.
A seasoned technology executive with a proven record of scaling multiple startups in e-commerce, agriculture, and blockchain technology, Linda Obi has been appointed to the position of Chief Executive Officer of Afrihealth.
AfriHealth, which is prepared for global expansion under her leadership and for which she currently serves as a board member on multiple other organisations, benefits from her vast experience.
About Afrihealth
Afrihealth is a leading technology solutions provider with headquarters in Nigeria. The company offers a wide variety of cutting-edge solutions that are aimed at resolving the most urgent problems in the healthcare industry.
The mission of Afrihealth is to increase access to high-quality medical care while also ensuring the safety of patients through the use of technology-enabled solutions.